Hepcinat LP (Generic Epclusa) in India

The drug Hepcinat LP is a competent combination of two active ingredients in one tablet form: Sofosbuvir and Ledipasvir. They are in an ideal therapeutic ratio - 400 mg of Sofosbuvir and 90 mg of Ledipasvir, which provides the fastest effect.

The mechanism of action of Hepcinat LP is based on the direct antiviral effect of its main components on the hepatitis C virus visions. They block and destroy the NS5B and NS5A proteins, the complex effect is aimed only at infected cells, healthy ones remain intact. Thus, full-fledged viral RNA cannot be formed and further destroy healthy cells, self-reproducing.

As a result, the spread of the virus stops, the viral load on the liver decreases. Since the liver can recover on its own over time, with the disappearance of the virus, this process goes faster, and the patient feels better every day.

The drug Hepcinat LP is manufactured at the production facilities of the Hetero concern, however, the official distributor of this drug is Natco.

The advent of Hepcinat LP Natco has given hope to millions of hepatitis C patients around the world because unlike the original Harvoni, the cost of the drug has become available to most. You can buy Generic Harvoni Online 99 times Cheaper than Original Harvoni.